Eyenovia, Inc.

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: US30234E1047

USD

3.97

0.06 (1.53%)

Dec 04

NAS

Click here to see other stocks

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Alpha Teknova, Inc.

DURECT Corp.

G1 Therapeutics, Inc.

ADC Therapeutics SA

Corvus Pharmaceuticals, Inc.

Kinnate Biopharma, Inc.

Eyenovia, Inc.

Immix Biopharma, Inc.

Evelo Biosciences, Inc.

Tiziana Life Sciences Ltd.

Zynerba Pharmaceuticals, Inc.

Why is Eyenovia, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Eyenovia, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Eyenovia, Inc.

-46.0%

-0.01

7679.75%

S&P 500

13.22%

0.61

20.17%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

0.79%

EBIT Growth (5y)

-7.34%

EBIT to Interest (avg)

-14.90

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.68

Sales to Capital Employed (avg)

0.01

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

22.58%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-1.45

EV to EBIT

-0.75

EV to EBITDA

-0.78

EV to Capital Employed

-6.72

EV to Sales

20.70

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

Negative BV

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bearish

Dow Theory

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

10What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD -19.94 MM

NET SALES(9M)

At USD 0.04 MM has Grown at 41.73%

NET PROFIT(HY)

Higher at USD -12.26 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 0.16 times

RAW MATERIAL COST(Y)

Fallen by -99.97% (YoY

-4What is not working for the Company

NET SALES(HY)

At USD 0.01 MM has Grown at -46.7%

Here's what is working for Eyenovia, Inc.

Net Profit

Higher at USD -12.26 MM

than preceding 12 month period ended Jun 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Debtors Turnover Ratio

Highest at 0.16 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Operating Cash Flow

Highest at USD -19.94 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Raw Material Cost

Fallen by -99.97% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Eyenovia, Inc.

Net Sales

At USD 0.01 MM has Grown at -46.7%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (USD MM)